QA: Viking Therapeutics Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001607678_2020_Viking_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001607678, Viking Therapeutics Inc

  xvar xval
0 AssetsCurrent 283,501,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 755,000
4 LiabilitiesCurrent 6,777,000
5 LiabilitiesNoncurrent 360,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,401,674
9 ResearchAndDevelopmentExpense 32,506,911
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 6,067,069
13 remainder_ComprehensiveNetIncome -402,189
  yvar yval
0 Assets 284,256,000
1 Liabilities 7,137,000
2 Expenses 41,908,585
3 Revenues 0
4 StockholdersEquity 277,119,000
5 NetIncome -35,841,516
6 ComprehensiveNetIncome -36,042,610
7 BaseVar 169,885,422
8 EconomicCapitalRatiobeforeLimitedLiability 3.90
9 EconomicCapitalRatio 4.32

Edgar->Model Mapping

Feature Distribution

Change over Time